Related Experiment Video
Updated: Jun 26, 2026

07:48
A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
Published on: September 22, 2011
Mining transcriptome data for function-trait relationship of hyper productivity of recombinant antibody
Salim Charaniya1, George Karypis, Wei-Shou Hu
1Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, 55455-0132, USA.
Biotechnology and Bioengineering
|January 10, 2009
Summary
High antibody production in mammalian cell cultures involves complex physiological changes. Key alterations in high-producing NS0 cell lines include protein processing, mitochondrial function, and cell cycle regulation.
Area of Science:
- Biotechnology
- Molecular Biology
- Cell Biology
Background:
- Mammalian cell culture processes have significantly advanced in productivity over the last decade.
- High-producing cell lines are crucial for synthesizing and secreting therapeutic proteins, driving process development.
Purpose of the Study:
- To understand the physiological functions linked to high antibody productivity in mammalian cell lines.
- To identify specific biological pathways and gene sets altered in high-producing cell lines.
Main Methods:
- Comparative transcriptome analysis of NS0 cell lines with varying antibody productivity.
- Gene Set Testing (GST) using three complementary tools: Gene Set Enrichment Analysis (GSEA), Gene Set Analysis (GSA), and MAPPFinder.
- Identification of up- and downregulated gene groups in high producers.
Main Results:
- High antibody production correlates with significant alterations in protein processing and transport pathways, including modification, vesicle trafficking, and turnover.
- Genes associated with mitochondrial ribosomal function, cell cycle regulation, and cytoskeleton elements are also differentially expressed in high producers.
- Identified functional classes provide insights into the biological underpinnings of enhanced productivity.
Conclusions:
- Simultaneous modulation of multiple physiological functions is a promising strategy for achieving high productivity in mammalian cell culture.
- Understanding these altered pathways can guide future engineering efforts for improved biotherapeutic production.
- Transcriptome analysis provides a powerful approach to elucidate complex traits like antibody productivity.
Related Concept Videos
Recombinant DNA
Overview
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

